Haleon plc (NYSE:HLN) Receives Average Rating of "Buy" from Analysts

Haleon plc (NYSE:HLN - Get Free Report) has been given an average recommendation of "Buy" by the six analysts that are presently covering the company, MarketBeat Ratings reports. One equities research analyst has rated the stock with a hold recommendation, four have assigned a buy recommendation and one has given a strong buy recommendation to the company. The average 1 year price objective among brokers that have issued ratings on the stock in the last year is $10.95.

HLN has been the topic of a number of research reports. UBS Group upgraded shares of Haleon to a "strong-buy" rating in a research report on Tuesday, October 1st. Morgan Stanley upped their price objective on shares of Haleon from $9.90 to $10.95 and gave the company an "overweight" rating in a report on Friday, September 20th.

Institutional Inflows and Outflows

Large investors have recently made changes to their positions in the business. Fortitude Family Office LLC acquired a new stake in shares of Haleon in the 3rd quarter worth about $28,000. Toronto Dominion Bank increased its holdings in Haleon by 3,470.0% during the 3rd quarter. Toronto Dominion Bank now owns 3,570 shares of the company's stock worth $38,000 after purchasing an additional 3,470 shares in the last quarter. Cultivar Capital Inc. purchased a new stake in shares of Haleon in the second quarter worth approximately $40,000. Prospera Private Wealth LLC bought a new position in shares of Haleon in the third quarter valued at approximately $57,000. Finally, BOKF NA boosted its position in shares of Haleon by 68.8% during the second quarter. BOKF NA now owns 6,972 shares of the company's stock valued at $58,000 after buying an additional 2,842 shares during the last quarter. 6.67% of the stock is owned by institutional investors.

Haleon Trading Up 2.0 %

HLN traded up $0.19 during trading on Tuesday, reaching $9.91. 10,257,378 shares of the stock traded hands, compared to its average volume of 5,438,782. Haleon has a 12 month low of $7.89 and a 12 month high of $10.80. The company has a quick ratio of 0.58, a current ratio of 0.84 and a debt-to-equity ratio of 0.44. The stock's 50-day moving average is $9.74 and its 200 day moving average is $9.54. The stock has a market capitalization of $44.86 billion, a PE ratio of 29.15, a P/E/G ratio of 2.95 and a beta of 0.28.

About Haleon

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.